SEC Form D · filed October 29, 2019
Engage Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
Orrin Devinsky · New York, NYDirectorGregory Mayes · Summit, NJExec · Director · PromoterHeath D. Lukatch · Fort Worth, TXDirectorGerry D. Brunk · Weston, MADirectorJouko D. Isojarvi · Durham, NCExecWarren Lammert · Boston, MADirectorStephen D. Collins · Lake Forest, ILDirectorMark Theeuwes · Summit, NJExecSire Management Corporation · New York, NYDirectorBruce S. Macdonald · NASHUA, NHExec · Director · PromoterDouglas F. Blough · NASHUA, NHDirectorSire Management Partners, L.P · New York, NYDirectorSam Eletr · San Francisco, CADirectorCaledonia (Private) Investments Pty Limited · SYDNEY NSW, Channel IslandsExecDominik W. Pozny · New York, NYDirectorDavid Kittle · San Diego, CADirectorDavid Gastfriend · BOSTON, MAExecThomas Gravina · Exton, PAExec · Director · PromoterFrederick Jones · Exton, PADirectorRichard Vague · Exton, PADirectorVirginia Stallings · Exton, PADirectorJames O'Connell · Exton, PADirectorMark Theeuwes · Summit, NJExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗